PHAR
Price
$9.78
Change
-$0.17 (-1.71%)
Updated
Oct 2, 03:46 PM (EDT)
Capitalization
740.86M
34 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$5.37
Change
-$0.31 (-5.46%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
242.19M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PHAR vs TRDA

PHAR vs TRDA Comparison Chart in %
View a ticker or compare two or three
VS
PHAR vs. TRDA commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAR is a StrongBuy and TRDA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
PHARTRDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (PHAR: $9.95 vs. TRDA: $5.68)
Brand notoriety: PHAR and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAR: 31% vs. TRDA: 103%
Market capitalization -- PHAR: $740.86M vs. TRDA: $242.19M
PHAR [@Biotechnology] is valued at $740.86M. TRDA’s [@Biotechnology] market capitalization is $242.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAR’s FA Score shows that 0 FA rating(s) are green while TRDA’s FA Score has 0 green FA rating(s).

  • PHAR’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than PHAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAR’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • PHAR’s TA Score: 3 bullish, 4 bearish.
  • TRDA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PHAR is a better buy in the short-term than TRDA.

Price Growth

PHAR (@Biotechnology) experienced а -4.69% price change this week, while TRDA (@Biotechnology) price change was -8.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

PHAR is expected to report earnings on Nov 05, 2026.

TRDA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
PHAR
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWO357.640.74
+0.21%
iShares Russell 2000 Growth ETF (IWO)
HYDW45.49-0.13
-0.29%
Xtrackers Low Beta High Yield Bond ETF (HYDW)
NIE24.90-0.10
-0.40%
Virtus Equity & Convertible Income Fund
COLO46.36-0.80
-1.70%
Global X MSCI Colombia ETF (COLO)
BMED33.77-0.79
-2.29%
iShares Health Innovation Active ETF (BMED)

PHAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAR has been loosely correlated with ENGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAR jumps, then ENGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAR
1D Price
Change %
PHAR100%
-0.40%
ENGN - PHAR
43%
Loosely correlated
-1.00%
TRDA - PHAR
41%
Loosely correlated
-10.55%
LKFT - PHAR
34%
Loosely correlated
-2.66%
INSM - PHAR
34%
Loosely correlated
-4.86%
LGND - PHAR
34%
Loosely correlated
-3.08%
More